Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 212,800 shares, an increase of 833.3% from the October 31st total of 22,800 shares. Based on an average daily volume of 1,855,900 shares, the short-interest ratio is presently 0.1 days.
Analyst Ratings Changes
RBGLY has been the subject of several analyst reports. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. UBS Group upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a report on Thursday, August 29th. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy”.
Get Our Latest Report on RBGLY
Reckitt Benckiser Group Stock Performance
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- What is the Shanghai Stock Exchange Composite Index?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- The How and Why of Investing in Gold Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What Are Dividend Champions? How to Invest in the Champions
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.